US 7319171
Sertraline hydrochloride form II and methods for the preparation thereof
granted A61PA61P25/24
Quick answer
US patent 7319171 (Sertraline hydrochloride form II and methods for the preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P25/24